Hong Kong SC P2
This role leads the end-to-end implementation of the MedTech Co-create Programme (MTCC), a pilot funding track designed to accelerate the commercialisation of healthcare innovations through structured co-creation. The appointee acts as the primary orchestrator of partnerships, project execution, funding disbursement, and performance monitoring while building awareness and refining the pilot for long-term ecosystem impact. The position involves identifying strategic corporate partnerships, matching corporate needs with Park companies' technologies, and managing the MTCC funding pool.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Hong Kong SC P2.
Hong Kong SC P2 didn’t post a salary, so this is our estimate from similar listings.
31% below the average for this role
Commercialisation Manager (Medtech)
Griffith University
Commercialisation Manager (Medtech)
Griffith University
Vice President, Sales - MedTech
Hippocratic AI
Senior Manager / Manager (Biomedical Sciences Industry Partnership Office – MedTech)
ASTARPRD
IP Commercialisation Channel Manager
C0001206658P
Commercialisation in Action
CSIRO